The Added Value of Contrast Enhancement for Guiding EUS-FNA in Solid Pancreatic Masses

P

Professor Dr. Seicean Andrada

Status

Completed

Conditions

Endoscopic Ultrasonography

Treatments

Diagnostic Test: Endosonography

Study type

Interventional

Funder types

Other

Identifiers

NCT03525847
10430

Details and patient eligibility

About

A prospective study designed to show the superiority of contrast guided echoendoscopy versus conventional echoendoscopy

Full description

A prospective study that compares the results using FNA contrast echoendoscopy versus standard FNA echoendoscopy in the diagnosis of solid pancreatic tumors

Enrollment

150 patients

Sex

All

Ages

18 to 86 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • solid pancreatic tumor lesions

Exclusion criteria

  • severe coagulopathy of trombocytopenia <50.000
  • patients refuse for biopsy prelevation or pacient's refuse to participate in the study

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

150 participants in 2 patient groups

contrast enhanced FNA endosonography
Active Comparator group
Description:
First passage in the solid pancreatic tumor using FNA endosonography then with the contrast enhanced FNA endosonography
Treatment:
Diagnostic Test: Endosonography
FNA standard endosonography
Active Comparator group
Description:
First passage in the solid pancreatic tumor using contrast enhanced FNA endosonography then with the FNA endosonography
Treatment:
Diagnostic Test: Endosonography

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems